Physician

Christopher Nathaniel Roybal, M.D

According to 2025 Medicare claims, Christopher Roybal, M.D (NPI: 1639375397) practices ophthalmology in the Albuquerque, NM market, with the plurality of this provider's patient population coming from Bernalillo, NM. This provider's primary affiliated billing organization is RETINA CONSULTANTS OF NEW MEXICO, LLC (NPI: 1558960799; TIN: 852218556) and primary practice location at 87113-2474.

Roybal's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 887 traditional Medicare patients, billed 78,590 HCPCS/CPT codes, and received $3,406,718 in Medicare payments. The top billing code was J2778 (Injection, ranibizumab, 0.1 mg). Part D data shows 733 prescription claims across 257 beneficiaries totaling $26,754 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 36 records totaling $8,854. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved sharply higher in recent years, from $43,798 to $3,406,718. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $21,051 and ending at $26,754. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	339	897	$43,798
2016	521	1,934	$257,763
2017	1,059	5,817	$897,718
2018	1,301	8,743	$1,751,233
2019	1,324	10,962	$2,459,468
2020	1,152	11,340	$2,576,103
2021	843	6,999	$1,714,880
2022	1,166	22,343	$4,185,953
2023	1,113	56,630	$3,809,027
2024	887	78,590	$3,406,718

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	62	168	$21,051
2016	99	222	$10,468
2017	184	516	$25,339
2018	240	777	$40,092
2019	304	1,003	$46,519
2020	270	963	$49,926
2021	227	558	$24,641
2022	254	811	$35,329
2023	258	791	$29,542
2024	257	733	$26,754

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
J2778	Injection, ranibizumab, 0.1 mg	182	3,024	$123
67028	Injection of drug into eye	416	1,744	$90
92014	Established patient complete exam of visual system	688	1,126	$80
92134	Imaging of retina	779	1,471	$28
J2777	Injection, faricimab-svoa, 0.1 mg	197	65,940	$27

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Prednisolone Acetate	Prednisolone Acetate	224	7,308	$7,055
Ofloxacin	Ofloxacin	158	4,838	$1,885
Latanoprost	Latanoprost	138	5,095	$1,485
Dorzolamide-Timolol	Dorzolamide Hcl/Timolol Maleat	57	4,312	$1,091
Ketorolac Tromethamine	Ketorolac Tromethamine	25	1,122	$784

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	36	$8,854	Genentech USA, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Christopher Nathaniel Roybal, M.D?

Tedicare shows public-source Medicare data for Christopher Nathaniel Roybal, M.D (NPI 1639375397), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Christopher Nathaniel Roybal, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Christopher Nathaniel Roybal, M.D?

Christopher Nathaniel Roybal, M.D is linked to RETINA CONSULTANTS OF NEW MEXICO, LLC (billing NPI 1558960799) in the available physician profile data.

Does Christopher Nathaniel Roybal, M.D have Open Payments data?

Christopher Nathaniel Roybal, M.D has 36 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.